Multimodality Imaging of Somatostatin Receptor–Positive Tumors with Nuclear and Bioluminescence Imaging
Multimodal bioluminescence (BLI) and single-photon emission computed tomography/computed tomography (SPECT/CT) imaging were investigated as means to monitor somatostatin receptor subtype 2 (SST 2 )-positive neuroendocrine tumors as both a subcutaneously implanted and a liver metastasis animal model...
Saved in:
| Main Authors: | Stefan E. Pool, Timo L.M. ten Hagen, Stuart Koelewijn, Marion de Jong, Gerben A. Koning |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2012-01-01
|
| Series: | Molecular Imaging |
| Online Access: | https://doi.org/10.2310/7290.2011.00024 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Somatostatin Receptor Imaging in the Diagnosis and Management of Parathyroid Neuroendocrine Neoplasia
by: Uliana Tsoy, et al.
Published: (2024-12-01) -
Somatostatin receptor molecular imaging in a misdiagnosed gastrinoma case
by: Cati Stolniceanu, et al.
Published: (2020-10-01) -
Signaling Can Be Uncoupled from Imaging of the Somatostatin Receptor Type 2
by: Lin Han, et al.
Published: (2007-11-01) -
Bioluminescence Imaging of Gene Expression in Utero
by: Meera T. Saxena, et al.
Published: (2007-01-01) -
Primary pancreatic lymphoma camouflaged under the umbrella of spectrum of neuroendocrine tumors in somatostatin receptor imaging
by: Nikita Sampathirao, et al.
Published: (2020-07-01)